Cargando…

Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application

Imiquimod is an immunomodulator with both antitumor and antiviral properties. It is currently available in two cream formulations as Aldara (imiquimod 5%) and the newly approved Zyclara (imiquimod 3.75%). Imiquimod has been associated with localized erythema, crusting, and scaling at the site of app...

Descripción completa

Detalles Bibliográficos
Autores principales: Atanaskova Mesinkovska, Natasha, Dawes, Danyelle, Sood, Apra, Bergfeld, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505938/
https://www.ncbi.nlm.nih.gov/pubmed/23198175
http://dx.doi.org/10.1155/2011/412684